United States State Authorities & Local Municipalities was 908 Devices’s largest revenue line in fiscal 2025, bringing in $24.24M of $56.20M (43%).
| Customer | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| United States Federal & Defense | — | $16.82M | $14.54M |
| Government | $38.23M | — | — |
| United States State Authorities & Local Municipalities | — | $17.54M | $24.24M |
| Rest Of World National & Provincial Organizations | — | $11.89M | $14.44M |
| Pharmaceutical/Biotechnology | $11.34M | — | — |
| Global Pharmaceutical, Industrial & Other | — | $1.50M | $2.99M |
| Academia & Other | $657.00K | — | — |
| Total | $50.23M | $47.75M | $56.20M |
908 Devices brought in $56.20M from its four revenue lines in fiscal 2025, the year ended December 31, 2025. That was up 17.7% from $47.75M in fiscal 2024. United States State Authorities & Local Municipalities was the largest at $24.24M (43.1%), ahead of United States Federal & Defense at $14.54M (25.9%) and Rest Of World National & Provincial Organizations at $14.44M (25.7%). The remaining revenue line, Global Pharmaceutical, Industrial & Other, brought in $2.99M.
Compared with fiscal 2024, Global Pharmaceutical, Industrial & Other grew fastest, up 98.6% to $2.99M, while United States Federal & Defense fell the most, down 13.6% to $14.54M.
908 Devices began breaking out United States Federal & Defense in fiscal 2024, United States State Authorities & Local Municipalities in fiscal 2024, Rest Of World National & Provincial Organizations in fiscal 2024 and Global Pharmaceutical, Industrial & Other in fiscal 2024. 908 Devices stopped reporting Government ($38.23M in fiscal 2023), Pharmaceutical/Biotechnology ($11.34M in fiscal 2023) and Academia & Other ($657.00K in fiscal 2023) as separate revenue lines.
Device Sales Revenue was 908 Devices’s largest product and service line in fiscal 2025, bringing in $36.66M of $56.20M (65%).
| Product and Service | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|
| Device Sales Revenue | $8.93M | $5.52M | $31.69M | $36.66M | ||
| Product & Service Revenue | $14.94M | $11.99M | — | — | ||
| Recurring Revenue | $9.71M | $10.01M | $15.93M | $19.42M | ||
| Service Revenue | $6.98M | $10.02M | — | — | ||
| License & Contract Revenue | — | — | — | — | ||
| Contract Revenue | — | $370.00K | $132.00K | $117.00K | ||
| Total | $40.55M | $37.91M | $47.75M | $56.20M |
908 Devices brought in $56.20M from its three product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 17.7% from $47.75M in fiscal 2024. Device Sales Revenue was the largest at $36.66M (65.2%), ahead of Recurring Revenue at $19.42M (34.6%) and Contract Revenue at $117.00K (0.2%).
Compared with fiscal 2024, Recurring Revenue grew 21.9% to $19.42M and Device Sales Revenue grew 15.7% to $36.66M.
908 Devices began breaking out Contract Revenue in fiscal 2023, when it brought in $370.00K. 908 Devices stopped reporting Product & Service Revenue ($11.99M in fiscal 2023) and Service Revenue ($10.02M in fiscal 2023) as separate lines.
United States was 908 Devices’s largest region in fiscal 2025, bringing in $41.25M of $56.20M (73%).
| Geography | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|
| United States | $37.59M | $38.17M | $35.65M | $41.25M | ||
| Americas | — | — | — | — | ||
| Europe, Middle East & Africa | $6.30M | $9.38M | $9.13M | $10.43M | ||
| Asia Pacific | $2.89M | $1.83M | $2.10M | $3.00M | ||
| Americas Other | $76.00K | $853.00K | $863.00K | $1.53M | ||
| Total | $46.85M | $50.23M | $47.75M | $56.20M |
908 Devices brought in $56.20M from its four regions in fiscal 2025, the year ended December 31, 2025. That was up 17.7% from $47.75M in fiscal 2024. United States was the largest at $41.25M (73.4%), ahead of Europe, Middle East & Africa at $10.43M (18.6%) and Asia Pacific at $3.00M (5.3%). The remaining region, Americas Other, brought in $1.53M.
Compared with fiscal 2024, Americas Other grew fastest, up 76.7% to $1.53M. Every region above 2% of revenue grew. From fiscal 2022 to 2025, combined revenue from these regions grew from $46.85M to $56.20M, a compound annual growth rate of 6.2%. United States' share of the total fell from 80.2% to 73.4%.
908 Devices (MASS) reports its revenue by customer, by product and service and by geography. In fiscal 2025, United States State Authorities & Local Municipalities was its largest revenue line, bringing in $24.24M (43.1% of the total), followed by United States Federal & Defense at $14.54M (25.9%).
United States State Authorities & Local Municipalities was 908 Devices' largest revenue line in fiscal 2025, bringing in $24.24M, or 43.1% of the $56.20M total across its four revenue lines.
Device Sales Revenue was 908 Devices' largest product and service line in fiscal 2025, bringing in $36.66M, or 65.2% of the $56.20M total across its three product and service lines.
United States was 908 Devices' largest region in fiscal 2025, bringing in $41.25M, or 73.4% of the $56.20M total across its four regions.
Among 908 Devices' revenue lines that make up at least 2% of revenue, Global Pharmaceutical, Industrial & Other grew fastest in fiscal 2025, up 98.6% from $1.50M to $2.99M.
Every figure comes from 908 Devices' annual financial filings, as reported. Each line keeps the name 908 Devices gives it, and years follow its fiscal calendar.
908 Devices' revenue by customer goes back to fiscal 2023, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.